Healthy Living: Delaying Diabetes
A new global study shows that an immunotherapy drug can delay the onset of type 1 diabetes for two years in high risk kids and adults.
Trial results are great news for the relatives of the millions of people with diabetes, who are fifteen times more likely to get the disease.
Courtney Hunter explains in Healthy Living.
Dr. Buckner says trials are being planned to extend the benefits of Teplizumab, perhaps even preventing diabetes altogether.